SPXV:NYE-ProShares S&P 500® ex-Health Care ETF (USD)

ETF | Large Blend |

Last Closing

USD 60.8083

Change

-0.58 (-0.95)%

Market Cap

USD 0.02B

Volume

1.70K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Under normal circumstances, the fund will invest at least 80% of its total assets in component securities of the index. The index and fund seek to provide exposure to the companies of the S&P 500® Index (the S&P 500®) with the exception of those companies included in the Health Care Sector.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Large Blend

Symbol Name Price(Change) Market Cap
VTI Vanguard Total Stock Market In..

-2.58 (-0.91%)

USD 439.91B
SPLG SPDR® Portfolio S&P 500 ETF

-0.63 (-0.93%)

USD 46.15B
SCHX Schwab U.S. Large-Cap ETF

-0.62 (-0.91%)

USD 45.97B
GSLC Goldman Sachs ActiveBeta® U.S..

-1.02 (-0.90%)

USD 12.90B
DYNF BlackRock US Equity Factor Rot..

-0.43 (-0.87%)

USD 11.77B
SPTM SPDR® Portfolio S&P 1500 Comp..

-0.61 (-0.87%)

USD 9.16B
SPLV Invesco S&P 500® Low Volatili..

+0.05 (+0.07%)

USD 7.54B
JQUA JPMorgan U.S. Quality Factor E..

-0.35 (-0.62%)

USD 5.08B
SCHK Schwab 1000 ETF

-0.57 (-1.03%)

USD 3.80B
SUSA iShares MSCI USA ESG Select

-1.28 (-1.06%)

USD 3.71B

ETFs Containing SPXV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Blend) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.86% 88% B+ 82% B
Dividend Return 1.03% 56% F 19% F
Total Return 21.88% 88% B+ 80% B-
Trailing 12 Months  
Capital Gain 37.30% 92% A 81% B-
Dividend Return 1.66% 62% D 22% F
Total Return 38.96% 93% A 80% B-
Trailing 5 Years  
Capital Gain 97.00% 78% C+ 84% B
Dividend Return 9.10% 70% C- 29% F
Total Return 106.10% 78% C+ 84% B
Average Annual (5 Year Horizon)  
Capital Gain 14.87% N/A N/A 78% C+
Dividend Return 16.24% N/A N/A 76% C+
Total Return 1.37% N/A N/A 32% F
Risk Return Profile  
Volatility (Standard Deviation) 19.85% N/A N/A 52% F
Risk Adjusted Return 81.80% N/A N/A 91% A-
Market Capitalization 0.02B 6% D- 12% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.